MedTrace Logo

Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine

NCT05309343 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2022-04-04

No results posted yet for this study

Summary

This is a cohort study performed in patients with cardiovascular diaeases who were treated with oral Chinese medicine and Western medicine. Collect indicators such as the incidence of cardiovascular events, all due to readmission, all due to death. To hospital using clinical samples to detect genomics, proteomics, metabolomics, intestinal flora and sclerotia.To explore the clinical efficacy of Chinese patent medicine in the treatment of cardiovascular diseases, and provide reliable data support for its clinical application.

Conditions

Interventions

DRUG

Chinese patent medicine

Shexiang Baoxin Pill, Tongxinluo Capsule, Tongmai Yangxin Pill, Xuefu Zhuyu Capsule, Qishen Yiqi Dropping Pill, etc.

Sponsors & Collaborators

  • Tianjin University of Traditional Chinese Medicine

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2024-04-01
Completion
2031-11-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05309343 on ClinicalTrials.gov